8-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

_____________

Form 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): May 15, 2014

OCEAN BIO-CHEM, INC.

(Exact name of registrant as specified in charter)

Florida	0-11102	59-1564329
(State or Other Jurisdiction of Incorporation)	(Commission File Number)	I.R.S. Employer Identification No.)

4041 S.W. 47 Avenue, Fort Lauderdale, Florida	33314
(Address of principal executive offices)	(Zip Code)

(954) 587-6280

Registrant’s telephone number, including area code:

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 2.02. Results of Operations and Financial Condition

Ocean Bio-Chem, Inc. (the “Company”) is furnishing, as Exhibits 99.1, press release it issued on May 15, 2014  that pertain to its financial results for the quarter ended March 31, 2014.

The information furnished pursuant to Item 2.02 of this Current Report, including the exhibits furnished herewith, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section, nor shall it be incorporated by reference into future filings by the Company under the Securities Act of 1933, as amended or under the Securities Exchange Act of 1934, as amended, unless the Company expressly sets forth in such future filing that such information is to be considered “filed” or incorporated by reference therein.

Item 9.01 Financial Statements and Exhibits

(d)           Exhibits

The Company is furnishing the following exhibits to this Current Report:

Exhibit Number	Description
99.1	Press release, dated May 15, 2014

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	OCEAN BIO-CHEM, INC.
Date: May 15, 2014	By:	/s/ Jeffrey S. Barocas
		Jeffrey S. Barocas
		Chief Financial Officer

EX-99.1

Exhibit 99.1

Ocean Bio-Chem, Inc. Reports First Quarter 2014 Financial Results

FORT LAUDERDALE, FL., May 15, 2014 -- Ocean Bio-Chem, Inc. (NASDAQ: OBCI), a leading manufacturer and distributor of appearance, performance, and maintenance products serving the marine, automotive, power sports, recreational vehicle and outdoor power equipment markets, announced today its financial results for the first quarter of 2014.

Net income was approximately $224,000 or $0.03 per share both basic & diluted, for the first quarter of 2014, compared to approximately $349,000 or $0.04 per share both basic & diluted for the first quarter of 2013.  The Company also reported first quarter 2014 net sales of approximately $5,921,000 compared to the first quarter of 2013 net sales of approximately $6,312,000.

(In thousands except per share data)	Quarter Ended
	March 31,
	2014		2013
Net sales	$	5,921	$	6,312
Pre-tax income	$	340	$	508
Net income	$	224	$	349
Earnings per share (both basic & diluted)	$	0.03	$	0.04
Dividends per share	$	0.05	$	--

Ocean Bio-Chem, Inc. President and CEO Peter Dornau stated, “As previously communicated, due to one of the coldest winters in many decades, the first quarter’s marine sector sales started off slower than we anticipated.  Customers in the Northern and Midwestern parts of the U.S continued to experience winter weather conditions, including snow, throughout the first quarter of 2014, delaying boat owners from putting their boats into the water.

"We are disappointed in the drop in sales.  However we have seen early indications of strong sales increases in the second quarter, as spring weather finally arrives in most parts of the United States.   We are cautiously optimistic that we will recover the shortfall of sales from the first quarter and we will exceed our 2013 six month sales results.

On a positive note, we had excellent first quarter growth sales of our fuel additive Star Tron. The Company recorded double digit sales growth of our Star Tron product group, which was led by increased sales to big box specialty retailers, and auto parts stores."

Mr. Dornau continued, “The Company is excited to have started transitioning from the research and development stages into the sales and marketing phase of our new Performacide® product group.   Performacide® is a disinfectant, sanitizer virucide, fungicide and deodorizer. We launched one of our new products from the family of Performacide® products at the National Hardware show in Las Vegas last week and received significant interest.  We are currently presenting the first Performacide® products to our existing customers and expect retail placement as soon as the third quarter of this year.  We anticipate sales of this product will increase earnings as we expand into new markets in 2015.

Mr. Dornau concluded, “The Company’s financial condition is strong.  We ended the first quarter with a current ratio of over 5:1. We were very pleased to be able to provide to our shareholders a special cash dividend of $0.05 per share.  This dividend demonstrates Ocean Bio-Chem's strong financial condition and our commitment to increasing shareholder value."

About Ocean Bio-Chem, Inc.:

Ocean Bio-Chem, Inc. is principally engaged in the manufacturing, marketing and distribution of a broad line of appearance and maintenance products for boats, recreational vehicles, automobiles, power sports, outdoor power equipment and motorcycle markets under the Star brite® StarTron® and other trademarks within the United States of America and Canada. In addition, the Company produces private label formulations of many of its products for various customers and provides custom blending and packaging services for these and other products.

The Company trades publicly under NASDAQ Capital Markets, Ticker Symbol: OBCI.

The Company's web sites are:  www.oceanbiochem.com, www.starbrite.com  www.startron.com, and www.nos-guard.com

Forward-looking Statements:

Certain statements contained in this Press Release, including without limitation, our anticipation of increased sales in 2014, stronger sales in the second quarter and six months of 2014 and the launch of Performacide® products later in the year.  For this purpose, any statements contained in this report that are not statements of historical fact may be deemed forward-looking statements.  Without limiting the generality of the foregoing, words such as "believe," "may," "will," "expect," "anticipate," "intend," or "could," including the negative or other variations thereof or comparable terminology, are intended to identify forward-looking statements.  These statements involve known and unknown risks, uncertainties and other factors which may cause actual results to be materially different from those expressed or implied by such forward-looking statements.  Factors that may affect these results include, but are not limited to, the highly competitive nature of our industry; reliance on certain key customers; changes in consumer demand for marine, recreational vehicle and automotive products; advertising and promotional efforts; exposure to market risks relating to changes in interest rates, foreign exchange rates, prices for raw materials that are petroleum or chemical based and other factors.

Contact:

Peter Dornau

CEO and President

pdornau@starbrite.com

954-587-6280

Jeff Barocas

Vice President & CFO

Jbarocas@starbrite.com

954-587-6280

Paul Knopick

E & E Communications

pknopick@eandecommunications.com

940-262-3584